Welcome Guest | Register / Login

Biotechnology Market Research Reports

Sort By
Title Published Price Buy Now
Kappa Antagonist - Pipeline Insight, 2019
By Delve Insight
"Kappa Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Kappa Antagonist development. The report provides detailed coverag...
Jan 2019 $ 1250
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Leucine-Rich Repeat Kinase (LRRK)-2 I...
Jan 2019 $ 1250
Leukotriene Antagonist - Pipeline Insight, 2019
By Delve Insight
"Leukotriene Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Leukotriene Antagonist development. The report provides deta...
Jan 2019 $ 1250
Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2019
By Delve Insight
"Lipoxygenase Inhibitor (LOX Inhibitor) - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Lipoxygenase Inhibitor (LOX Inhibitor) devel...
Jan 2019 $ 1250
Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Low Affinity Sodium Glu...
Jan 2019 $ 1250
Lysine Specific Demethylase 1 (LSD-1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Lysine Specific Demethylase 1 (LSD-1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Lysine Specific Demethylase 1 (LSD-...
Jan 2019 $ 1250
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Matrix...
Jan 2019 $ 1250
Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Matrix Metalloproteinase 9 (MMP-9) Inh...
Jan 2019 $ 1250
Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2019
By Delve Insight
"Metabotropic Glutamate Receptor Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Metabotropic Glutamate Receptor Agonist dev...
Jan 2019 $ 1250
Methionine Aminopeptidase 2 (Metap2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Methionine Aminopeptidase 2 (Metap2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Methionine Aminopeptidase 2 (Metap2)...
Jan 2019 $ 1250
Mitochondrial Electron Transport Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Mitochondrial Electron Transport Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Mitochondrial Electron Transport Inhibit...
Jan 2019 $ 1250
Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Mitogen Activated ...
Jan 2019 $ 1250
Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Mitogen Activ...
Jan 2019 $ 1250
Monoamine Oxidase Inhibitor (MAOIs) - Pipeline Insight, 2019
By Delve Insight
"Monoamine Oxidase Inhibitor (MAOIs) - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Monoamine Oxidase Inhibitor (MAOIs) development...
Jan 2019 $ 1250
Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Monoamine Oxidase B (MAO-B) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Monoamine Oxidase B (MAO-B) Inhibitor develop...
Jan 2019 $ 1250
mTORC-1 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"mTORC-1 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "mTORC-1 Inhibitor development. The report provides detailed cover...
Jan 2019 $ 1250
mTORC-2 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"mTORC-2 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "mTORC-2 Inhibitor development. The report provides detailed cover...
Jan 2019 $ 1250
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Murine Double Minute 2 (MDM2) Inhibitor dev...
Jan 2019 $ 1250
Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2019
By Delve Insight
"Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Muscarinic Acetylcholine Receptor M...
Jan 2019 $ 1250
Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2019
By Delve Insight
"Muscarinic Acetylcholine Receptor M3 Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Muscarinic Acetylcholine Receptor M...
Jan 2019 $ 1250
Muscarinic Agonist - Pipeline Insight, 2019
By Delve Insight
"Muscarinic Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Muscarinic Agonist development. The report provides detailed cov...
Jan 2019 $ 1250
Muscarinic M1 Agonist - Pipeline Insight, 2019
By Delve Insight
"Muscarinic M1 Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Muscarinic M1 Agonist development. The report provides detail...
Jan 2019 $ 1250
Neurokinin (NK) Receptor Antagonist - Pipeline Insight, 2019
By Delve Insight
"Neurokinin (NK) Receptor Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Neurokinin (NK) Receptor Antagonist development...
Jan 2019 $ 1250
Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Neuronal Nitric Oxide...
Jan 2019 $ 1250
Neutrophil Elastase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Neutrophil Elastase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Neutrophil Elastase Inhibitor development. The report...
Jan 2019 $ 1250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy